ijms-logo

Journal Browser

Journal Browser

Nanoparticles for Tumor Imaging and Therapy 2.0

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 1559

Special Issue Editor


E-Mail Website
Guest Editor
Department of Chemical Sciences, University of Naples “Federico II”, Complesso Universitario di Monte S. Angelo, Via Cupa Nuova Cinthia 21, 80126 Naples, Italy
Interests: organic synthesis; natural compounds; functional materials; nanoparticles; luminescent compounds; NMR spectroscopy; mass spectrometry; UV-visible and fluorescent spectroscopy; thin film processing
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In this century, nanoparticles (NPs) have been given a great amount of attention by biomedical researchers. NPs can disperse hydrophobic drugs stably in aqueous conditions without aggregation. Importantly, their physicochemical properties, including size and surface charge, can easily be modified by adjusting the component molecules or fabrication method. NPs can delay the early release of drugs in order to allow sufficient time for therapeutic action.

In terms of tumor-targeting, NPs utilize two basic strategies comprising either passive or active targeting. Passive targeting is based on physicochemical properties. Specifically, when NPs are injected intravenously, they generally circulate longer in the blood stream compared to free drugs. In angiogenic tissues such as tumors, NPs penetrate the fenestrated structure of blood vessels more at the disease site, which in turn leads to significant accumulation of the drug, which is aided in part by slow lymphatic drainage. On the other hand, active targeting relies on a biological interaction between ligands on the surface of NPs and the cell target, which further increase specificity.

Considering these advantages of NPs as carriers, this Special Issue will explore the biomedical application of NPs based on polymers and targeted to tumors.

Prof. Dr. Paola Manini
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanoparticle
  • nanomedicine
  • polymer
  • drug delivery
  • imaging
  • chemotherapy
  • tumor-targeting
  • self-assembly
  • tumor therapy
  • photodynamic therapy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

27 pages, 4032 KiB  
Review
Multifunctional Nanoplatform for NIR-II Imaging-Guided Synergistic Oncotherapy
by Qingluo Wang, Guoyu Xia, Jianmin Li, Longlong Yuan, Shujie Yu, Dingyang Li, Nan Yang, Zhongxiong Fan and Jinyao Li
Int. J. Mol. Sci. 2023, 24(23), 16949; https://doi.org/10.3390/ijms242316949 - 29 Nov 2023
Viewed by 1234
Abstract
Tumors are a major public health issue of concern to humans, seriously threatening the safety of people’s lives and property. With the increasing demand for early and accurate diagnosis and efficient treatment of tumors, noninvasive optical imaging (including fluorescence imaging and photoacoustic imaging) [...] Read more.
Tumors are a major public health issue of concern to humans, seriously threatening the safety of people’s lives and property. With the increasing demand for early and accurate diagnosis and efficient treatment of tumors, noninvasive optical imaging (including fluorescence imaging and photoacoustic imaging) and tumor synergistic therapies (phototherapy synergistic with chemotherapy, phototherapy synergistic with immunotherapy, etc.) have received increasing attention. In particular, light in the near-infrared second region (NIR-II) has triggered great research interest due to its penetration depth, minimal tissue autofluorescence, and reduced tissue absorption and scattering. Nanomaterials with many advantages, such as high brightness, great photostability, tunable photophysical properties, and excellent biosafety offer unlimited possibilities and are being investigated for NIR-II tumor imaging-guided synergistic oncotherapy. In recent years, many researchers have tried various approaches to investigate nanomaterials, including gold nanomaterials, two-dimensional materials, metal sulfide oxides, polymers, carbon nanomaterials, NIR-II dyes, and other nanomaterials for tumor diagnostic and therapeutic integrated nanoplatform construction. In this paper, the application of multifunctional nanomaterials in tumor NIR-II imaging and collaborative therapy in the past three years is briefly reviewed, and the current research status is summarized and prospected, with a view to contributing to future tumor therapy. Full article
(This article belongs to the Special Issue Nanoparticles for Tumor Imaging and Therapy 2.0)
Show Figures

Figure 1

Back to TopTop